Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Outcome research: rationales and objectives].

A Olivieri1, G Recchia, F Roila

  • 1Glaxo Wellcome SpA, Verona, Italia.

Tumori
|March 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iodine Nutrition in Emilia-Romagna Region, Italy: A Successful Story of Prevention of Iodine Deficiency Disorders.

Endocrine, metabolic & immune disorders drug targets·2026
Same author

Transfusion dependence is a risk factor for severe infections in myelodysplastic syndromes.

Leukemia research·2022
Same author

Inner southern magnetosphere observation of Mercury via SERENA ion sensors in BepiColombo mission.

Nature communications·2022
Same author

Stochastic epigenetic mutations as possible explanation for phenotypical discordance among twins with congenital hypothyroidism.

Journal of endocrinological investigation·2022
Same author

Phototherapy and topical treatments for cutaneous graft vs. host disease in haematopoietic stem cell transplantation patients: a scoping review.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Salt reduction and iodine intake in Italy.

Journal of endocrinological investigation·2021
Same journal

End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, Italy.

Tumori·2026
Same journal

Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposal.

Tumori·2026
Same journal

Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.

Tumori·2026
Same journal

Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC.

Tumori·2026
Same journal

Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.

Tumori·2026
Same journal

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Tumori·2026
See all related articles

Outcome research evaluates the real-world value of cancer treatments by assessing clinical, economic, and humanistic outcomes. Key patient outcomes like survival, toxicity, and Quality of Life are crucial for guiding clinical practice decisions.

Area of Science:

  • Pharmacoeconomics and Health Outcomes Research
  • Clinical Oncology

Background:

  • Outcome research assesses clinical, economic, and humanistic results of therapies in patient populations.
  • Oncology is a key area due to new, expensive cancer treatments often lacking proven survival or Quality of Life benefits.

Purpose of the Study:

  • To describe patient and disease-specific outcomes in oncology.
  • To evaluate the transferability of clinical trial results to real-world clinical practice.

Main Methods:

  • Review of outcome research principles and applications in drug development and clinical practice.
  • Identification of critical patient outcomes for anti-cancer therapies.

Main Results:

  • Survival, drug toxicity, and Quality of Life are paramount patient outcomes in oncology.

Related Experiment Videos

  • American Society of Clinical Oncology identified patient-specific outcomes as critical for assessing treatment value.

    • Conclusions:

    • Outcome research is vital for determining the true value of cancer therapies beyond initial registration.
    • Assessing survival, toxicity, and Quality of Life is essential for evidence-based clinical recommendations in oncology.